Hellerstein DJ
New York State Psychiatric Institute, Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY, United States.
ArticlePsilocybin
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.
ArticlePsychedelics
Trends in the psychedelic renaissance: applying artificial intelligence to measure media portrayal of psychedelic drugs in the 21st century.
ArticlePsilocybin
Provider perspectives on challenges in treatment during psychedelic therapy.
ArticlePsilocybin
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].
ArticlePsychedelics
Psychedelic Therapies: One Drug, Multiple Treatments Reply to Modesto-Lowe et al.
ArticlePsilocybin
The Role of Touch in Psychedelic Therapy: Perspectives From a Survey of Practitioners in Research Settings.
ArticlePsilocybin
Psychological Support Approaches in Psychedelic Therapy: Results From a Survey of Psychedelic Practitioners.
ArticlePsilocybin
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.
ArticlePsilocybin
Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.
ArticlePsilocybin
Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder.
PreprintPsilocybin
Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing
ArticlePsilocybin